7 medical -related ETF applications were approved on the same day, including the first batch of 3 vaccine theme ETFs

On July 5th, Capital State learned that the official website of the China Securities Regulatory Commission showed that the first batch of three national certificates vaccines and biotechnology ETF funds and the first batch of 4 Chinese medicine ETFs were officially approved on July 5.

Specifically, the three national certificate vaccines and biotechnology ETFs were reported by Huatai Berry Fund, Cathay Fund, and Wells Fund.It is approved and is expected to be issued in the near future.

Figure source: official website of the China Securities Regulatory Commission

In addition, the four Chinese medicine ETFs were reported by Huatai Berry Fund, Penghua Fund, Yinhua Fund, and Huitianfu Fund.Among them, Huatai Berry Fund's report time was August 2021, and Penghua Fund reported it in November of the same year. Yinhua and Huitianfu Fund were reported in January and June this year.

The official website of the China Securities Regulatory Commission also shows that there are currently six vaccine -related theme funds in the process of approval, which are reported by the Castrol Fund, Penghua Fund, Huaxia Fund, Boshi Fund, and China Merchants Fund.

- END -